Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Role of liver biopsy in the era of direct-acting antivirals.

Gonzalez HC, Jafri SM, Gordon SC.

Curr Gastroenterol Rep. 2013 Feb;15(2):307. doi: 10.1007/s11894-012-0307-z. Review.

PMID:
23319086
2.

Noninvasive methods to assess liver disease in patients with hepatitis B or C.

Castera L.

Gastroenterology. 2012 May;142(6):1293-1302.e4. doi: 10.1053/j.gastro.2012.02.017. Review.

PMID:
22537436
3.

[Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].

Pár A, Vincze Á, Pár G.

Orv Hetil. 2015 May 24;156(21):855-61. doi: 10.1556/650.2015.30173. Review. Hungarian.

PMID:
26038993
4.

Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.

Kim JH, Kim MN, Han KH, Kim SU.

Liver Int. 2015 Apr;35(4):1103-15. doi: 10.1111/liv.12628. Epub 2014 Jul 19. Review.

PMID:
24976523
5.

Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.

Enomoto M, Morikawa H, Tamori A, Kawada N.

World J Gastroenterol. 2014 Sep 14;20(34):12031-8. doi: 10.3748/wjg.v20.i34.12031. Review.

6.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

7.

Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C.

Crisan D, Radu C, Grigorescu MD, Lupsor M, Feier D, Grigorescu M.

J Gastrointestin Liver Dis. 2012 Dec;21(4):375-82.

8.

Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.

Ogawa E, Furusyo N, Shimizu M, Ihara T, Hayashi T, Harada Y, Toyoda K, Murata M, Hayashi J.

Antivir Ther. 2015;20(2):185-92. doi: 10.3851/IMP2805. Epub 2014 Jun 18.

PMID:
24941012
9.

[New non-invasive tool for assessment of liver fibrosis: transient elastography].

Horváth G.

Orv Hetil. 2011 May 29;152(22):860-5. doi: 10.1556/OH.2011.29094. Review. Hungarian.

PMID:
21565752
10.

[Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].

González Guilabert MI, Hinojosa Mena-Bernal C, del Pozo González J, del Pozo Pérez MA.

Gastroenterol Hepatol. 2010 Jun-Jul;33(6):425-32. doi: 10.1016/j.gastrohep.2010.02.005. Epub 2010 May 14. Spanish.

PMID:
20471720
11.

[Non invasive markers using for the assessment of fibrosis in hepatitis C].

Zarski JP, Bedossa P, Bronowicki JP, Doffoel M, Poynard T.

Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S34-9. Review. French.

12.

Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases.

Corpechot C.

Clin Liver Dis. 2016 Feb;20(1):143-58. doi: 10.1016/j.cld.2015.08.013. Epub 2015 Oct 9. Review.

PMID:
26593296
13.

[Measurement of liver elasticity can differentiate high and low grade fibrosis. New method can reduce the need of liver biopsy in chronic hepatitis C].

Wejdmark A, Weiland O.

Lakartidningen. 2009 Dec 9-21;106(50-51):3420-3. Swedish. No abstract available.

PMID:
20180445
14.

Is liver biopsy still needed in children with chronic viral hepatitis?

Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, Pluta M, Marczyńska M.

World J Gastroenterol. 2015 Nov 14;21(42):12141-9. doi: 10.3748/wjg.v21.i42.12141. Review.

15.

Staging of liver disease: which option is right for my patient?

Bhogal H, Sterling RK.

Infect Dis Clin North Am. 2012 Dec;26(4):849-61. doi: 10.1016/j.idc.2012.08.002. Review.

PMID:
23083819
16.

Chronic hepatitis C and liver fibrosis.

Sebastiani G, Gkouvatsos K, Pantopoulos K.

World J Gastroenterol. 2014 Aug 28;20(32):11033-53. doi: 10.3748/wjg.v20.i32.11033. Review.

17.

How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?

Sebastiani G, Alberti A.

J Viral Hepat. 2012 Jan;19 Suppl 1:18-32. doi: 10.1111/j.1365-2893.2011.01518.x.

PMID:
22233410
18.

Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review.

Kucharska M, Inglot M, Kuliszkiewicz-Janus M, Pazgan-Simon M, Knysz B.

Adv Clin Exp Med. 2015 Jul-Aug;24(4):671-7. doi: 10.17219/acem/22913. Review.

19.

Real-time tissue elastography: non-invasive evaluation of liver fibrosis in chronic liver disease due to HCV.

Shiraishi A, Hiraoka A, Aibiki T, Okudaira T, Kawamura T, Imai Y, Tatsukawa H, Yamago H, Nakahara H, Shimizu Y, Suga Y, Azemoto N, Tanihira T, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Hiasa Y, Matsuura B, Kawasaki H, Furuya K, Michitaka K.

Hepatogastroenterology. 2014 Oct;61(135):2084-90.

PMID:
25713914
20.

Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Lee S, Kim DY.

World J Gastroenterol. 2014 Jan 14;20(2):445-59. doi: 10.3748/wjg.v20.i2.445. Review.

Supplemental Content

Support Center